Cargando…
Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review
Treatment of patients with metastatic renal cell carcinoma (mRCC) and end-stage renal disease (ESRD) on dialysis poses a therapeutic challenge, particularly as this patient group was excluded from the pivotal clinical trials. In addition, there is uncertainty regarding drug dosing/pharmacokinetics,...
Autores principales: | Ansari, Jawaher, Ali, Muhammad, Farrag, Ashraf, Ali, Arwa M., Alhamad, Abdulaziz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020478/ https://www.ncbi.nlm.nih.gov/pubmed/30009063 http://dx.doi.org/10.1155/2018/1623957 |
Ejemplares similares
-
Concurrent use of nivolumab and radiotherapy for patients with metastatic non-small cell lung cancer and renal cell carcinoma with oligometastatic disease progression on nivolumab
por: Ansari, Jawaher, et al.
Publicado: (2021) -
Rare Case of Intracardiac Renal Cell Carcinoma Metastasis with Response to Nivolumab: Case Report and Literature Review
por: Ansari, Jawaher, et al.
Publicado: (2018) -
Longer Control of Nivolumab in Metastatic Renal Cell Carcinoma Patients with End-Stage Kidney Disease on Dialysis
por: Morinaga, Ryota, et al.
Publicado: (2019) -
Outcomes of Dialysis Among Patients With End-Stage Renal Disease (ESRD)
por: Ejaz, Ayesha, et al.
Publicado: (2021) -
Efficacy of temsirolimus in metastatic chromophobe renal cell carcinoma
por: Venugopal, Balaji, et al.
Publicado: (2013)